These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24687505)

  • 21. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.
    Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of oral quercetin in hamsters infected with
    Dos Santos RF; Da Silva T; Brito ACS; Inácio JD; Ventura BD; Mendes MAP; Azevedo BF; Siqueira LM; Almeida-Amaral EE; Dutra PML; Da-Silva SAG
    Front Cell Infect Microbiol; 2022; 12():1059168. PubMed ID: 36710981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis.
    Van Bocxlaer K; Caridha D; Black C; Vesely B; Leed S; Sciotti RJ; Wijnant GJ; Yardley V; Braillard S; Mowbray CE; Ioset JR; Croft SL
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():129-138. PubMed ID: 30922847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triphenylmethane derivatives have high in vitro and in vivo activity against the main causative agents of cutaneous leishmaniasis.
    de Souza Pietra RC; Rodrigues LF; Teixeira E; Fried L; Lefkove B; Rabello A; Arbiser J; Ferreira LA; Fernandes AP
    PLoS One; 2013; 8(1):e51864. PubMed ID: 23341885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis.
    Yamamoto ES; Campos BL; Jesus JA; Laurenti MD; Ribeiro SP; Kallás EG; Rafael-Fernandes M; Santos-Gomes G; Silva MS; Sessa DP; Lago JH; Levy D; Passero LF
    PLoS One; 2015; 10(12):e0144946. PubMed ID: 26674781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Licochalcone a Exhibits Leishmanicidal Activity
    Souza JM; de Carvalho ÉAA; Candido ACBB; de Mendonça RP; Fernanda da Silva M; Parreira RLT; Dias FGG; Ambrósio SR; Arantes AT; da Silva Filho AA; Nascimento AN; Costa MR; Sairre MI; Veneziani RCS; Magalhães LG
    Front Vet Sci; 2020; 7():527. PubMed ID: 33363224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility to paromomycin in clinical isolates and reference strains of Leishmania species responsible for tegumentary leishmaniasis in Brazil.
    Coser EM; Ferreira BA; Yamashiro-Kanashiro EH; Lindoso JAL; Coelho AC
    Acta Trop; 2021 Mar; 215():105806. PubMed ID: 33385363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Paradoxical Leishmanicidal Effects of Superoxide Dismutase (SOD)-Mimetic Tempol in
    Oliveira LB; Celes FS; Paiva CN; de Oliveira CI
    Front Cell Infect Microbiol; 2019; 9():237. PubMed ID: 31297344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis.
    Monzote L; Montalvo AM; Almanonni S; Scull R; Miranda M; Abreu J
    Chemotherapy; 2006; 52(3):130-6. PubMed ID: 16636536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis.
    Ávila Brustolin A; Fernandes Herculano Ramos-Milaré ÁC; Perles de Mello TF; Alessi Aristides SM; Campana Lonardoni MV; Verzignassi Silveira TG
    Exp Parasitol; 2022; 236-237():108244. PubMed ID: 35259404
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Rebouças-Silva J; Santos GF; Filho JMB; Berretta AA; Marquele-Oliveira F; Borges VM
    Front Cell Infect Microbiol; 2022; 12():1045732. PubMed ID: 36704104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania species.
    de Morais-Teixeira E; Rabello A; Aguiar MMG
    J Antimicrob Chemother; 2019 Aug; 74(8):2318-2325. PubMed ID: 31049550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.
    Giudice A; Camada I; Leopoldo PT; Pereira JM; Riley LW; Wilson ME; Ho JL; de Jesus AR; Carvalho EM; Almeida RP
    BMC Infect Dis; 2007 Feb; 7():7. PubMed ID: 17316450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous leishmaniasis infection in Balb/c mice using a Leishmania tropica strain isolated from Turkey.
    Girginkardeşler N; Balcioğlu IC; Yereli K; Ozbilgin A; Ozbel Y
    J Parasitol; 2001 Oct; 87(5):1177-8. PubMed ID: 11695390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
    Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
    Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.
    Rizk YS; Santos-Pereira S; Gervazoni L; Hardoim DJ; Cardoso FO; de Souza CDSF; Pelajo-Machado M; Carollo CA; de Arruda CCP; Almeida-Amaral EE; Zaverucha-do-Valle T; Calabrese KDS
    Front Cell Infect Microbiol; 2021; 11():615814. PubMed ID: 33718267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions.
    Peniche AG; Renslo AR; Melby PC; Travi BL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6463-70. PubMed ID: 26239994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.